IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET
The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effective innovative drugs and leads to unnecessary ex...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2018-02-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/215 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849696756523073536 |
|---|---|
| author | V. A. Lemeshko N. Z. Musina V. K. Fedyaeva |
| author_facet | V. A. Lemeshko N. Z. Musina V. K. Fedyaeva |
| author_sort | V. A. Lemeshko |
| collection | DOAJ |
| description | The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effective innovative drugs and leads to unnecessary expenses of the national budget. In this article, we propose a novel concept of price control relevant to Russia, which is based on the approaches used elsewhere. |
| format | Article |
| id | doaj-art-cbc694845ede468bb4492485ad43040d |
| institution | DOAJ |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2018-02-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-cbc694845ede468bb4492485ad43040d2025-08-20T03:19:21ZrusIRBIS LLCФармакоэкономика2070-49092070-49332018-02-01104253010.17749/2070-4909.2017.10.4.025-030189IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGETV. A. Lemeshko0N. Z. Musina1V. K. Fedyaeva2M. Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russian Federation; Centre of Expertise and quality control of Russian Ministry of Health careM. Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russian Federation; Centre of Expertise and quality control of Russian Ministry of Health careThe Russian Presidential Academy of National Economy and Public Administration; Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget InstitutionThe current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effective innovative drugs and leads to unnecessary expenses of the national budget. In this article, we propose a novel concept of price control relevant to Russia, which is based on the approaches used elsewhere.https://www.pharmacoeconomics.ru/jour/article/view/215price regulationmethods of pricinginnovation indexvalue-oriented pricing |
| spellingShingle | V. A. Lemeshko N. Z. Musina V. K. Fedyaeva IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET Фармакоэкономика price regulation methods of pricing innovation index value-oriented pricing |
| title | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET |
| title_full | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET |
| title_fullStr | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET |
| title_full_unstemmed | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET |
| title_short | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET |
| title_sort | improvement of price regulation for innovative medicines covered by the national budget |
| topic | price regulation methods of pricing innovation index value-oriented pricing |
| url | https://www.pharmacoeconomics.ru/jour/article/view/215 |
| work_keys_str_mv | AT valemeshko improvementofpriceregulationforinnovativemedicinescoveredbythenationalbudget AT nzmusina improvementofpriceregulationforinnovativemedicinescoveredbythenationalbudget AT vkfedyaeva improvementofpriceregulationforinnovativemedicinescoveredbythenationalbudget |